Jianhua Xu

机构：Fujian Medical University, Anhui Medical University, Second Affiliated Hospital of Fujian Medical University, China Telecom (China), First Affiliated Hospital of Anhui Medical University, Datang Telecom Group (China)

发表论文 123 篇 · 总被引 4108 次 · h-index 33

代表论文

• Guidelines for the diagnosis and treatment of osteoarthritis in China (2019 edition) (2020 · Annals of Translational Medicine · 被引 173)
• Leflunomide versus azathioprine for maintenance therapy of lupus nephritis: a prospective, multicentre, randomised trial and long-term follow-up (2022 · Annals of the Rheumatic Diseases · 被引 35)
• BAFF, involved in B cell activation through the NF-κB pathway, is related to disease activity and bone destruction in rheumatoid arthritis (2021 · Acta Pharmacologica Sinica · 被引 34)
• Comparison of the Efficacy and Safety of Adalimumab (Humira) and the Adalimumab Biosimilar Candidate (HS016) in Chinese Patients with Active Ankylosing Spondylitis: A Multicenter, Randomized, Double-Blind, Parallel, Phase III Clinical Trial (2020 · BioDrugs · 被引 30)
• Baricitinib in patients with rheumatoid arthritis with inadequate response to methotrexate: results from a phase 3 study. (2020 · PubMed · 被引 29)
• Low-Dose Methotrexate for the Treatment of Inflammatory Knee Osteoarthritis (2025 · JAMA Internal Medicine · 被引 21)